Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
So why is CCEL DILUTING. I READ THAT
Did you hear that or did you read it somewhere ?
KEEP WASTING MONEY CCEL. I heard Dan Richards wasn't Paid his two $200,000 a year salary this year. Is this what he is Worth for Sexually Attacking Wanda Dearth or is he Worth more! STAY TUNED LMAO = Another Proxy OUT =
Additional Proxy Soliciting Materials - Non-Management (definitive) (DFAN14A)
Date :
06/26/2012 @ 11:42AM
Source :
Edgar (US Regulatory)
Stock :
Cryo-Cell Intl (CCEL)
Quote :
2.32 0.0 (0.00%) @ 5:01PM
- Additional Proxy Soliciting Materials - Non-Management (definitive) (DFAN14A)
Print
Alert
SCHEDULE 14A
(RULE 14a-101)
INFORMATION REQUIRED IN PROXY STATEMENT
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
Filed by the Registrant ¨
Filed by a Party other than the Registrant ý
Check the appropriate box:
¨
Preliminary Proxy Statement
¨
Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
¨
Definitive Proxy Statement
¨
Definitive Additional Materials
ý
Soliciting Material Pursuant to §240.14a-12
CRYO-CELL INTERNATIONAL, INC.
(Name of Registrant as Specified in Its Charter)
Ki Yong Choi
(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)
Payment of Filing Fee (Check the appropriate box):
ý No fee required.
¨ Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
1.
Title of each class of securities to which transaction applies:
2.
Aggregate number of securities to which transaction applies:
3.
Per unit price or other underlying value of transaction computed pursuant to Exchange Act
Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
4.
Proposed maximum aggregate value of transaction:
5.
Total fee paid:
¨ Fee paid previously with preliminary materials:
¨ Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the form or schedule and the date of its filing.
1.
Amount previously paid:
2.
Form, Schedule or Registration Statement No.:
3.
Filing Party:
4.
Date Filed:
Take Action to Save Cryo-Cell from Further Enriching Co-CEOs
VOTE THE GOLD PROXY CARD
STOCK OPTION POOL AUTHORIZED BY THE BOARD, IF FULLY ISSUED, WOULD DILUTE CURRENT STOCKHOLDER OWNERSHIP BY APPROXIMATELY 22%
San Francisco, CA. - June 26, 2012 /PRNewswire/-- Ki Yong Choi, who owns 2,186,568 shares of common stock of Cryo-Cell International, Inc. (OTCBB: CCEL), or approximately 19.6% of the company's outstanding shares, today issued the following letter to stockholders of Cryo-Cell.
ELECT A BOARD THAT IS COMMITTED TO ACTING IN THE BEST INTERESTS OF ALL STOCKHOLDERS
THE CURRENT BOARD APPROVED WHAT I BELIEVE TO BE EGREGIOUSLY COSTLY EMPLOYMENT CONTRACTS, EXCESSIVE STOCKHOLDER DILUTION AND SQUANDERING OF CASH. I DO NOT BELIEVE THESE ACTIONS SHOW REGARD FOR STOCKHOLDER VALUE.
Dear Fellow Cryo-Cell Stockholder:
I have launched a proxy contest to elect a slate of Board members to chart a new direction for the company. I have been involved with Cryo-Cell for over six years and I am the company’s largest stockholder. I have launched this contest because I believe the co-CEOs and the current members of the Board are mismanaging the company by, among other things, granting to the co-CEOs lavish compensation and stock incentives.
Vote the Gold Proxy Card to Change this Pattern
Brothers David Portnoy and Mark Portnoy conducted a proxy contest starting approximately one year ago. After winning the contest and taking control of Cryo-Cell near the end of August 2011, the newly-elected Board gave the Portnoys the co-CEO title, salaries that I believe are exorbitant, 600,000 stock options with no performance related vesting criteria, 600,000 more performance related stock options for next fiscal year and substantial change in control severance packages. The Board also reimbursed the Portnoy Group for litigation costs incurred by David Portnoy, even though a judge had denied his request for reimbursement.
These benefits have been awarded, despite what I believe is mismanagement of the company and deteriorating financial results. Find below a timeline of benefits and compensation awarded to the Portnoys (or Portnoy Group) by the Board.
August 2011 – Portnoy brothers appointed co-CEOs, at combined salaries in excess of the salary of the prior CEO. The Board appointed the Portnoy brothers as co-CEOs and gave them a combined salary that exceeded the previous CEO’s salary by more than $50,000 1 despite the fact their proxy statement stated they would “reduce executive cash compensation”.
August 2011 – 200,000 options granted immediately to the co-CEOs. The Board granted to each of the brother co-CEOs 100,000 options 2 . There were no vesting related performance criteria associated with these grants and they vest over two years with one third of the options vesting on the date of grant.
August 2011 – Cryo-Cell repaid to the Portnoy Group costs related to the litigation filed by David Portnoy in 2007 . The Board approved payment to the Portnoy Group for expenses related to David Portnoy’s proxy contest litigation in 2007, even though a judge had denied his request for reimbursement. 3
December 2011 - New stock option pool of 1,500,000 shares . Fresh off a large stock option grant the brother co-CEOs and the Board created the 2012 Equity Incentive Plan to reserve 1,500,000 shares for additional grants. 4
December 2011 - 3 months on the job = 400,000 more options unrelated to performance . The Board granted the brother co-CEOs a total of 400,000 additional options priced at $1.72 per share that vest over two years 5 . There were no performance related vesting criteria associated with these grants.
December 2011 - 600,000 performance-related options for the brother co-CEOs . The Board approved an additional 600,000 options for next fiscal year for the brother co-CEOs 6 . I believe the performance related vesting criteria of these grants are easily achievable and not necessarily related to the company’s operating performance.
December 2011 – Liberal change in control provision. Not only do I believe that the severance benefits are exorbitant, but the brother co-CEOs can collect them not only if there is a change in control due to a new Board, but also if someone simply submits a competing proxy solicitation. Should there be a change in control prior to December 1, 2012, 600,000 options automatically vest and the brother co-CEOs get a severance package of $850,000. If the change in control happens after October 31, 2013, the 600,000 performance-related options are granted and automatically vest.
December 2011 –Performance criteria for co-CEO bonuses I believe are easily achievable . The Board set three criteria that would allow the brother co-CEOs to collect 100% of their $425,000 cash salary bonus 7 . With 2.3 million shares remaining in the company’s share repurchase plan, I believe that further share repurchases will help the brother co-CEOs achieve at least two of their performance goals; the third performance goal remains a mystery. Unfortunately for Cryo-Cell stockholders, repurchasing shares drains the company’s cash reserves and does not improve the operating performance of the company.
A summary of the vesting criteria is as follows:
·
Criteria 1 - Diluted revenue per share of $1.75 . I believe the management team can reach this goal by keeping revenue flat and repurchasing shares 8 .
·
Criteria 2 - Stock price of $3.75 – Cryo-Cell stock currently trades about 5,000 shares per day – if the company repurchases up to 2.3 million shares, the stock price will likely increase.
·
Criteria 3 – Unstated . In the company’s SEC filing, the Board stated the third criteria “consists of subjective performance, as determined in the sole discretion of the Committee after consultation with the Executive .” Based on the Board’s generosity to the brother co-CEOs to this point, I believe this criterion will only favor the brother co-CEOs, as all of the other activities stated above do.
May 2012 - All options in the 2012 Equity Incentive Plan have been granted so Board reserves one million more. Having granted all of the 1,500,000 shares included in the 2012 Equity Incentive Plan within in six months, the Board added 1,000,000 more shares to the Plan, which now totals 2,500,000 shares 9 . This can result in more than 22% dilution to the stockholder base if fully issued . This option pool expansion comes directly after the company reported significant losses in its February 2012 fiscal quarter.
I BELIEVE THE SHARE BUY BACK PROGRAM IS NOT IN THE BEST INTERESTS OF THE COMPANY.
I DO NOT BELIEVE THE ACTIONS OF THIS BOARD SHOW THEY ARE LOOKING OUT FOR ALL STOCKHOLDERS.
To recap: in six months the Board gave the Portnoys the co-CEO title, what I believe are exorbitant salaries, 600,000 options with no performance related vesting criteria, 600,000 more performance-related options for next fiscal year, and substantial change in control severance packages. The Board also reimbursed the Portnoy Group for litigation costs that had been denied to David Portnoy in his 2007 legal action. I cannot think of one way these actions benefit stockholders.
I have carefully chosen what I believe to be a well-rounded group of independent Director nominees with whom I have no existing business relationship. I believe that each Director brings important industry expertise, contacts and the kind of specialized experience that I believe is required to drive stockholder value for Cryo-Cell. As a team, we are completely dedicated to turning around Cryo-Cell.
VOTE THE GOLD PROXY CARD TO MAKE A DIFFERENCE IN CRYO-CELL’S FUTURE
Time is short. No matter how many or how few shares you own, it is important that you return the GOLD proxy card and vote in favor of electing us to represent you in the boardroom. You should WAIT TO RECIEVE the definitive proxy materials and the GOLD proxy card that will be mailed to you. You SHOULD NOT RETURN THE WHITE PROXY CARD or any other proxy card furnished to you on behalf of Cryo-Cell.
What should you do now? Once you receive a GOLD proxy card, vote to elect directors who will work for all of Cryo-Cell’s stockholders by signing and returning the GOLD proxy card .
If you have already returned a proxy card, you have every right to change your vote by signing and returning a later-dated GOLD proxy card once it is provided to you.
As the largest stockholder and a person who cares about Cryo-Cell, I vow to work tirelessly to get the company back on track. I thank you and look forward to your support.
Ki Yong Choi
Investor Contact:
Alliance Advisors LLC.
Call Toll Free: (877) 777-2338;
Banks and Brokers Call Collect: (973) 873-7700.
--------------------------------------------------------------------------------
1 SEC form 10-K filed 2-28-12 and SEC form 8-K filed 12-7-2011.
2 SEC form 10-Q filed 10-17-2011, p. 15. Options granted August 31, 2011.
3 SEC form 10-Q filed 10-17-2011, p. 20. Payment approved August 31, 2011. Also see Portnoy v. Cryo-Cell International, Inc. decided by the Delaware Court of Chancery on January 15, 2008.
4 SEC form 8K filed 12-7-2011. 2012 Equity Incentive Plan approved by Board 12-1-2011.
5 SEC form 8K filed 12-7-2011. Employment agreement that granted options approved by Board 12-1-2011.
6 SEC form 8K filed 12-7-2011. Employment agreement that granted options approved by Board 12-1-2011.
7 SEC form 8K filed 12-7-2011. Employment agreements for David and Mark Portnoy, Section 3.b. approved by Board 12-1-2011.
8 Per SEC form 10-Q filed 4-16-2012 the company had 11,488,980 diluted shares as of February 29, 2012. With revenue of $17.9 million in the last fiscal year and 11.2 million shares outstanding, if management directs the company to repurchase 1.26 million shares and holds revenue flat, the company will achieve the diluted revenue per share target of $1.75.
9 SEC form DEFC14A filed June 21, 2012, p. 26.
In connection with his intended proxy solicitation, on June 25, 2012 Ki Yong Choi filed a definitive proxy statement with the Securities and Exchange Commission (the “SEC”) to solicit stockholders of Cryo-Cell International, Inc. MR. CHOI STRONGLY ADVISES ALL STOCKHOLDERS OF CRYO-CELL INTERNATIONAL, INC. TO READ THE PROXY STATEMENT BECAUSE IT CONTAINS IMPORTANT INFORMATION, INCLUDING INFORMATION RELATING TO THE PARTICIPANTS IN SUCH PROXY SOLICITATION. THE PROXY STATEMENT AND ANY OTHER RELEVANT DOCUMENTS ARE AVAILABLE AT NO CHARGE ON THE SEC’S WEBSITE AT HTTP://WWW.SEC.GOV.
PARTICIPANT INFORMATION
In accordance with Rule 14a-12(a)(1)(i) under the Securities Exchange Act of 1934, as amended, the following persons are anticipated to be, or may be deemed to be, participants in any such proxy solicitation: Ki Yong Choi, Gary Weinhouse, Michael W. Cho, Warren Hoeffler, Michael D. Coffee and Ajay Badlani. Certain of these persons hold direct or indirect interests in Cryo-Cell International, Inc. as follows: Mr. Choi holds of record or beneficially a total of 2,186,568 shares of Cryo-Cell International, Inc.’s common stock and Dr. Michael W. Cho is the record holder of 14,166 shares of Cryo-Cell International, Inc.’s common stock. Messrs. Choi, Weinhouse, Cho, Hoeffler, Coffee and Badlani each have an interest in being nominated and elected as a director of Cryo-Cell International, Inc. Information about the participants has been set forth in the definitive proxy statement filed by Mr. Choi with the SEC on June 25, 2012.
Yup everyone is running for the exit , not .
EXCESSIVE STOCKHOLDER DILUTION ELECT A BOARD THAT IS COMMITTED TO ACTING IN THE BEST INTERESTS OF ALL STOCKHOLDERS
THE CURRENT BOARD APPROVED WHAT I BELIEVE TO BE EGREGIOUSLY COSTLY EMPLOYMENT CONTRACTS, EXCESSIVE STOCKHOLDER DILUTION AND SQUANDERING OF CASH. I DO NOT BELIEVE THESE ACTIONS SHOW REGARD FOR STOCKHOLDER VALUE.
Typical CCEL CRAP!
CCELs EXCESSIVE DILUTION. THATS JUST GREAT!
A rarity in a world of greed. Kudos to Choi!
That's what I mean, a whistle-blower who has the #'s to call someone a$$ out lol, love it.
Amusing, but the #'s back up his claim - no denying that.
I actually found it quite amusing lol
I wish Choi would tell us how he REALLY felt.......
What kind of PR is that lol?
http://ih.advfn.com/p.php?pid=nmona&article=52893135&symbol=CCEL
So, what happens if he sells?
The POOR BROTHERS ARE GOING HAVE TO EXPECT THAT IF CHOI DOESN'T GET HIS WAY HE WILL SELL ALL HIS SHARES. GOOD IT SERVES THE POOR BROTHERS RIGHT. S
So why do you call them the POOR BROTHERS ? Did they invest their money into the competitor's stock that lost over 90% of its value after a 1 for 100 RS . If they did , then yes they're POOR pps 0.013 OUCH, OUCH, OUCH CCEL $2.36 LMAO
I feel sorry for The Poor Brothers they thought they would do better then Mercedes who did they think they were fooling. Its your time to go Poor Brothers AND CHOI HAS BOTH OF YOUR DOSE OF REALITY!
As many as they need , why do you call them the POOR BROTHERS ?
How About PROXI! LMAO How many more Proxy Contest can CCEL Survive
Why do you call them the POOR BROTHERS ?
Hello THE POOR BROTHERS WANT TO TAKE CCEL PRIVATE. BUT THEN THERE IS CHOI. WHAT DOES CHOI WANT ONLY REVENUES AND WHAT MANAGEMENT PROMISED AND NEVER FULFILLED.
So what if he sells them ? I thought you said they were going private , what happened to that theory ? I'm confused as to what to "STAY TUNED" for . I'm still STAYING TUNED for CCEL's competittor to take away CMEX or crush CCEL . I mean the competitor is at 0.013 after a 1 for 100 RS , should I still STAY TUNED for thise event's to take place ?
Will CCELs Biggest Shareholder Sell all his shares, STAY TUNED! !!!!
Got about as much chance of that as CCEL.s poor competitor making an offer to buy CCEL or take CMEX or crush CCEL LMAO
Has CCEL Released any CCEL NEWS besides Proxy pissing Contest! Cryo-Cell Intl (CCEL)
$ 2.32 ? 0.12 (5.45%)
Volume: 5,975
Add CCEL To Streamer
Add CCEL To My Stocks
Add CCEL Price Alert
Share
Bid Ask Last Traded Open Prev Close
2.09 2.40 5:04:31 PM EST 2.21 2.20
Day's Range 52-Wk Range Avg Volume EPS P/E
2.20 - 2.35 1.57 - 3.10 5,802 -0.35 N/A
Market Cap Outstanding Float Dividend / Yield Ex-Div Date
26.54M 11.44M 8.24M N/A N/A
Short Interest Short % of Float Insider B/S Inst % Owned Exchange
N/A N/A 43,000 N/A OTCBB
Support 2 Support 1 Pivot Price Resistance 1 Resistance 2
$ 2.14 $ 2.23 $ 2.29 $ 2.38 $ 2.44
Trade Cryo-Cell Intl with
More CCEL News Recent Cryo-Cell Intl, CCEL News
Proxy Soliciting Materials (revised) (PRRN14A)
Edgar (US Regulatory) • Fri Jun 22,2012 1:31 PM (4 hours ago)
Revised Proxy Soliciting Materials (definitive) (DEFR14A)
Edgar (US Regulatory) • Thu Jun 21,2012 5:32 PM
Proxy Statment - Contested Solicitations (definitive) (DEFC14A)
Edgar (US Regulatory) • Thu Jun 21,2012 4:16 PM
Proxy Soliciting Materials (revised) (PRER14A)
Edgar (US Regulatory) • Tue Jun 19,2012 4:39 PM
Additional Proxy Soliciting Materials - Non-Management (definitive) (DFAN14A)
Edgar (US Regulatory) • Tue Jun 19,2012 2:53 PM
Proxy Soliciting Materials (revised) (PRRN14A)
Edgar (US Regulatory) • Tue Jun 19,2012 2:41 PM
Ki Yong Choi Sends Letter to Cryo-Cell Stockholders
PR Newswire • Tue Jun 19,2012 8:30 AM
Proxy Soliciting Materials (revised) (PRER14A)
Edgar (US Regulatory) • Fri Jun 15,2012 5:30 PM
Additional Proxy Soliciting Materials - Non-Management (definitive) (DFAN14A)
Edgar (US Regulatory) • Thu Jun 7,2012 5:28 PM
Amended Statement of Beneficial Ownership (3/A)
06/07/2012
5:28PM
EDGAR
Additional Proxy Soliciting Materials - Non-Management (definitive) (DFAN14A)
OTCBB:CCEL
Cryo-Cell Intl
06/07/2012
4:44PM
EDGAR
Amended Statement of Beneficial Ownership (3/A)
OTCBB:CCEL
Cryo-Cell Intl
06/07/2012
1:45PM
Form (8-K)
Current report filing
OTCBB:CCEL
Cryo-Cell Intl
06/06/2012
1:28PM
EDGAR
Proxy Statements not involving Contested Solicitations (preliminary) (PREN14A)
OTCBB:CCEL
Cryo-Cell Intl
06/01/2012
5:31PM
EDGAR
Additional Proxy Soliciting Materials - Non-Management (definitive) (DFAN14A)
OTCBB:CCEL
Cryo-Cell Intl
06/01/2012
5:30PM
EDGAR
Amended Statement of Beneficial Ownership (SC 13D/A)
OTCBB:CCEL
Cryo-Cell Intl
05/31/2012
6:06PM
Form (3)
Initial Statement of Beneficial Ownership
OTCBB:CCEL
Cryo-Cell Intl
05/31/2012
6:05PM
Form (4)
Statement of Changes in Beneficial Ownership
OTCBB:CCEL
Cryo-Cell Intl
05/22/2012
5:20PM
Form (8-K)
Current report filing
OTCBB:CCEL
Cryo-Cell Intl
05/03/2012
12:45PM
Form (8-K)
Current report filing
OTCBB:CCEL
Cryo-Cell Intl
04/18/2012
5:17PM
Form (4)
Statement of Changes in Beneficial Ownership
OTCBB:CCEL
Cryo-Cell Intl
04/17/2012
6:06AM
Form (8-K)
Current report filing
OTCBB:CCEL
Cryo-Cell Intl
04/16/2012
5:41PM
PRNUS
Cryo-Cell Reports Financial Results for First Quarter 2012
OTCBB:CCEL
Cryo-Cell Intl
04/16/2012
5:16PM
Form (10-Q)
Quarterly Report
OTCBB:CCEL
Cryo-Cell Intl
03/14/2012
3:47PM
Form (4)
Statement of Changes in Beneficial Ownership
OTCBB:CCEL
Cryo-Cell Intl
03/14/2012
3:46PM
Form (3)
Initial Statement of Beneficial Ownership
OTCBB:CCEL
Cryo-Cell Intl
03/09/2012
5:19PM
Form (8-K)
Current report filing
OTCBB:CCEL
Cryo-Cell Intl
02/29/2012
4:36PM
Form (4)
Statement of Changes in Beneficial Ownership
OTCBB:CCEL
Cryo-Cell Intl
02/29/2012
4:26PM
Form (4)
Statement of Changes in Beneficial Ownership
OTCBB:CCEL
Cryo-Cell Intl
02/29/2012
2:59PM
Form (8-K)
Current report filing
OTCBB:CCEL
Cryo-Cell Intl
02/29/2012
1:45PM
PRNUS
Cryo-Cell Reports Financial Results for Fiscal 2011
OTCBB:CCEL
Cryo-Cell Intl
02/28/2012
5:32PM
Form (10-K)
Annual Report
CCEL will be CRAP once the POOR Brothers run out of Money! Will CHOI save CCEL in time!
No if the pps was 0.013 after a 1 for 100 RS like it's competitor then you could call it crap .
CCEL is only up because Management is the Only one Buying Shares of this crap!
CCEL $2.36 , proxy , proxy , no one cares .
MORE NEWS ANOTHER CCEL PROXY!CCEL SHOULD JUST CHANGE THEIR TICKER TO PROXY = Ki Yong Choi is the record holder of 42,600 shares of common stock, par value $0.01 per share, of Cryo-Cell International, Inc., a Delaware corporation (the “Company”), and the beneficial holder of an additional 2,143,968 shares of the Company’s common stock, representing a total of 2,186,568 shares or approximately 19.56% of the Company’s outstanding shares of common stock. Mr. Choi is writing to you in connection with the election of six director nominees (the “Nominees”) to the Company’s Board of Directors at the annual meeting of stockholders scheduled to be held at the Courtyard by Marriott, 4014 Tampa Road, Oldsmar, Florida 34677 at 11:00 a.m. local time, on Tuesday, July 10, 2012, including any adjournments or postponements of it and any meeting which may be called in lieu of it (the “Annual Meeting”). This proxy statement (the “Proxy Statement”) and the enclosed GOLD proxy card are first being furnished to stockholders on or about June [_____], 2012. This Proxy Statement and the enclosed GOLD proxy card are being furnished to the Company’s stockholders by Mr. Choi and the other participants in this solicitation (collectively, the “Participants”) identified in the section entitled “Participants in the Solicitation,” in connection with the solicitation of proxies from the Company’s stockholders for the following purposes:
win some and lose some. Other penny stocks have cost me, but oh well.
thanks
Really? Show me a press release issued by the company or a company rep that says that it is a "proxy fight".
All the articles I've seen that state this are written by independant journalists trying to make it sound more interesting, so people will read it. In other words, it is someone elses opinion to call it a fight - not the company (called "dirty laundry in the news business). Dirty laundry is what sells news,
By the way: if it isn't written by the company or a company rep, it isn't a press release - it is just a news article. Big difference.
Press Release - Definition of Press Release on Investopedia - News that is sent out or released by the company making the news.
Ok , soooooo what does that have to do with CCEL's current situation ? Answer , nothing ,nothing , nothing
Funny when Almost all of CCELs Press Releases Read Proxy Fight! LMAO
Doesn't that make sense "cut your nose to spite your face" it makes perfect sense to some .
GLTY
Right - he's going to teach the Portnoys a lesson by selling his shares at a price less than what he could if he managed his sales properly.
That will sure teach them not to mess with him!
He's a businessman - I'm sure he will treat it as such.
Busnessmen don't get and stay rich by getting emotional.
NO I SAID MERCEDES NEVER BOUGHT ANY CCEL SHARES !!!!!!
Or he could end up PISSED OFF and Sell it all.The only Problem I see is that only Management is Buying .
MAKE UP MY MIND . I THOUGHT YOU ALWAYS SAID SHE HAS NO SHARES , WHEN DID THAT CHANGE OR MAYBE SHE OWNS $300.00 WORTH LIKE THAT OTHER EX CEO .
Depends on how fast he wants to unload and if there are buyers willing to pay his ask price.
With that amount of stock, it's basic "supply and demand" economics.
He would be smart to trickle it into the float, reducing votility.
Mercedes was the OLD CEO for CCEL RIGHT ! Where is the Shares she Bought?
And tell me or us what does Mercedes have to do with any of this ? Answer , NOTHING .
Weird a 100 buy yesterday and CCEL was up 15 percent what will happen when Choi sells all of his!
Mercedes NEVER BOUGHT SHARES and that's a FACT!
Really you think these guys would risk all their holdings ? Remember unlike their crusher competitor they put out real money , not $300.00. STAY TUNED
Why would they need to?
Please Management isn't prepared to Buy back all of CHOI's shares.
WE WILL FIND OUT SOON ENOUGH IF CCEL GOES ON FIRE SALE.THE POOR BROTHERS HAVE A CHANCE TO STEP TO THE SIDE OR RISK LOSING THEIR MAJOR SHAREHOLDER. ROTFLMFAO!!!!!!!!!!!!!
No - it would depend on who bought them, and at what price.
Followers
|
28
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
5497
|
Created
|
05/26/05
|
Type
|
Free
|
Moderators |
Cryo-Cell International, Inc.(CCEL)
Company Information:
700 Brooker Creek Blvd.
Suite 1800
Oldsmar, FL 34677
Phone: 813-749-2100
Toll Free: 800-786-7235
Fax: 813-855-4745
Cryo-Cell International, Inc. was established in 1989 with a primary focus on the cryopreservation of umbilical cord (U-Cord®) stem cells for family use. Since our inception, we have been committed to the development and adoption of industry best practices and technologies.
Cord blood stem cell transplants have already changed-and saved-thousands of lives around the world. What's more, science is honing in on other miraculous uses for these precious cells, potentially impacting countless numbers of lives in the future.
Ever-committed to the highest quality, we treat every specimen of umbilical cord blood as if it were our own. Every sample we receive, process and preserve represents a potentially life-saving treatment for a child. This concept fuels our resolve to only hire the most talented candidates, develop and implement the most effective training and continuously fine-tune our processes. From the design and specifications of our collection kit, to the choice of each supplier, our dedication to quality remains unwavering.
Cryo-Cell International, Inc. ("the Company" or "Cryo-Cell") operates in one reportable segment and is principally engaged in cellular processing and cryogenic storage, with a current focus on the collection and preservation of umbilical cord (U-Cord®) blood stem cells for family use. The Company, in combination with its global affiliates currently stores over 200,000 cord blood specimens worldwide for the exclusive benefit of newborn babies and possibly other members of their families. The Company is one of the world's largest and most established private family cord blood stem cell banks in terms of the number of specimens preserved. Its headquarters facility in Oldsmar, Florida handles all aspects of its U.S.-based business operations, including the processing and storage of specimens. The specimens are stored in commercially available cryogenic storage units at the Company's technologically and operationally advanced facility in Oldsmar, Florida.
In recent years, the Company has expanded its research and development ("R&D") activities to develop technologies related to stem cells other than umbilical cord blood stem cells such as fetal and maternal stem cells harvested from the placenta. During 2006, the Company discovered novel technology related to menstrual stem cells. In November 2007, the Company announced the launch of its C'elleSM service related to this patent-pending technology, and the Company continues to focus its current research and development activities principally on the C'elle service and related new menstrual stem cell technologies. The Company is actively marketing the C'elle service which is available both through a bundled offer with the Company's U-Cord service and on a stand-alone basis.
Employees: At November 30, 2009, there are 48 full-time employees and 1 part-time employee on the staff of the Company. Additional employees and staff will be hired on an "as needed" basis. The Company believes its relationship with its employees is good. None of our employees are members of any labor union, and we are not a party to any collective bargaining agreement.
Here's a video which shows the importance of saving cord blood: http://video.foxnews.com/11461523/cord-blood-miracle/?category_id=949437d0db05ed5f5b9954dc049d70b0c12f2749
Cryo-Cell International, Inc. holds an equity position in Saneron CCEL Therapeutics (Saneron), a University of South Florida spin-out biotechnology company. Saneron is committed to advancing research using readily available, non-controversial cord blood stem cells. Saneron's research focus is to actively seek new cellular therapy discoveries for treatment of and intervention in devastating, life-threatening illness and conditions such as heart attack, Alzheimer's disease, stroke, and spinal cord injury.
For more information, visit Saneron's Web site: www.saneron-ccel.com
Cryo-Cell is International
In order to provide the Cryo-Cell U-Cord® Stem Cell Preservation Service abroad, we are establishing affiliates in countries around the world. Currently, we have affiliates in the following areas:
See page 15 of SEC filing for further details: http://www.sec.gov/Archives/edgar/data/862692/000119312511189394/d10q.htm
C'elle distributor opportunity for doctors that specialize in female issues. See video:
http://www.celle.com/distributorVideo.aspx#
_______________________________________________________________________________________________________________________________________________________
Cryo-Cell International, Inc. has been a publicly traded company since 1991. Governed by the Securities & Exchange Commission, our common stock trades under the OTC Bulletin Board symbol CCEL. We specialize in U-Cord® stem cell preservation for family use.
Investor Relations: http://www.cryo-cell.com/investor_relations/
Investor Information: To request Cryo-Cell's Investor's Information Kit, or to receive Cryo-Cell's press releases via email, please fill out this form: http://www.cryo-cell.com/investor_relations/investor_info.asp
Section 16 Filings: All Insiders Annual Reports Quarterly & Other Reports Stock Quote Fundamentals News Chart Real-Time Filings
_______________________________________________________________________________________________________________________________________________________
Recent News:
http://www.cryo-cell.com/investor_relations/
http://finance.yahoo.com/q/h?s=CCEL.OB+Headlines
http://www.nasdaq.com/aspxcontent/newsheadlines.aspx?symbol=CCEL&selected=CCEL&SourceCode=PMZ
Filings:
Transfer Agent:
Continental Stock Transfer & Trust Company
17 Battery Place, 8th Floor
New York 10004
__________________________________________________________________________________________________________________________
Share Structure:
See SEC filing link for latest share structure info.
______________________________________
All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
Also, keep in mind that moderators may or may not have a position in said stock. Being a moderator isn't a sign of endorsement.
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |